Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Pain 2Neoplasm Metastasis 2Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Agnosia 1

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Morphine 8Analgesics, Opioid 8Acetaminophen 8Fentanyl 7Dexmedetomidine 7Lidocaine 6Anesthesia, General 6Saline Solution 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Surveys and Questionnaires 4Sodium Chloride 4Pregabalin 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Therapeutics 2Tea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Agnosia × Samarium-153 × Clear all
NCT00374751 2019-08-26

Effect of Samarium on the Relief of Pain Due to Vertebral Metastases

New York Presbyterian Brooklyn Methodist Hospital

Phase 1/2 Completed
29 enrolled

Agnosia, Neoplasm Metastasis, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡